What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Osteoporosis
His scientific interests lie mostly in Osteoporosis, Internal medicine, Bone mineral, Physical therapy and Bone density.
The concepts of his Osteoporosis study are interwoven with issues in Prospective cohort study, Surgery and Cohort.
His research is interdisciplinary, bridging the disciplines of Endocrinology and Internal medicine.
His work deals with themes such as Cortical bone, High-performance liquid chromatography, Biochemistry and Dentistry, which intersect with Bone mineral.
His Cortical bone study combines topics from a wide range of disciplines, such as Lysyl oxidase, Quantitative computed tomography and Urology.
His Physical therapy study integrates concerns from other disciplines, such as Longitudinal study, Observational study and Cohort study.
His most cited work include:
- Obesity is not protective against fracture in postmenopausal women: GLOW. (343 citations)
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension (299 citations)
- A meta-analysis of the association of fracture risk and body mass index in women (272 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Osteoporosis, Internal medicine, Bone mineral, Endocrinology and Physical therapy.
His Osteoporosis research focuses on subjects like Surgery, which are linked to Nuclear medicine.
He usually deals with Internal medicine and limits it to topics linked to Osteoarthritis and Strontium ranelate.
Roland Chapurlat combines subjects such as Bone density, Placebo, Dentistry and Femoral neck with his study of Bone mineral.
His Physical therapy research is multidisciplinary, relying on both Cohort study and FRAX.
His work carried out in the field of Quantitative computed tomography brings together such families of science as Cortical bone and Tibia.
He most often published in these fields:
- Osteoporosis (39.52%)
- Internal medicine (40.83%)
- Bone mineral (20.09%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (40.83%)
- Osteoporosis (39.52%)
- Cohort (13.32%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Osteoporosis, Cohort, Osteoarthritis and Bone mineral.
His research on Internal medicine often connects related areas such as Gastroenterology.
His biological study spans a wide range of topics, including Prospective cohort study and Bone remodeling.
His research integrates issues of Bone tissue and Cancellous bone in his study of Bone remodeling.
Roland Chapurlat has included themes like Cohort study, Relative risk, Quantitative computed tomography, Post-hoc analysis and Hazard ratio in his Cohort study.
His study explores the link between Bone mineral and topics such as Cortical bone that cross with problems in Tibia, Femur fracture, Endocrinology and Bisphosphonate.
Between 2018 and 2021, his most popular works were:
- Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study (84 citations)
- Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. (34 citations)
- Guidelines for the assessment of bone density and microarchitecture in vivo using high-resolution peripheral quantitative computed tomography (32 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
Roland Chapurlat mostly deals with Internal medicine, Osteoporosis, Osteoarthritis, Odds ratio and Bone remodeling.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Placebo.
As a part of the same scientific family, Roland Chapurlat mostly works in the field of Placebo, focusing on Strontium ranelate and, on occasion, Physical therapy.
His Osteoporosis study often links to related topics such as Prospective cohort study.
His Prospective cohort study research is multidisciplinary, incorporating elements of Bone mineral, Cohort and FRAX.
In his research, Resorption, Bone resorption, Urology, Cancellous bone and Romosozumab is intimately related to Bone tissue, which falls under the overarching field of Bone remodeling.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
